Stefan Jovinge
31 – 40 of 51
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2006
-
Mark
Engraftment of engineered ES cell-derived cardiomyocytes but not BM cells restores contractile function to the infarcted myocardium
(
- Contribution to journal › Article
-
Mark
Glycemic and non-glycemic effects of pioglitazone in triple oral therapy in patients with type 2 diabetes mellitus
(
- Contribution to journal › Article
- 2005
-
Mark
Absence of the protease inhibitor cystatin C in inflammatory cells results in larger plaque area in plaque regression of apoE-deficient mice.
(
- Contribution to journal › Article
-
Mark
Conjugated linoleic acid increased C-reactive protein in human subjects
(
- Contribution to journal › Article
-
Mark
Lack of the Cysteine-Protease Inhibitor Cystatin C Promotes Atherosclerosis in Apolipoprotein E-Deficient Mice.
(
- Contribution to journal › Article
-
Mark
Nt-proANP in plasma, a marker of salt sensitivity, is reduced in type 2 diabetes patients.
(
- Contribution to journal › Article
- 2004
-
Mark
Inhibition of Tumor Necrosis Factor-{alpha} Reduces Atherosclerosis in Apolipoprotein E Knockout Mice.
(
- Contribution to journal › Article
-
Mark
Elevated Plasma Levels of Nt-proBNP in Patients With Type 2 Diabetes Without Overt Cardiovascular Disease.
(
- Contribution to journal › Article
-
Mark
Bone marrow-derived hematopoietic cells generate cardiomyocytes at a low frequency through cell fusion, but not transdifferentiation.
(
- Contribution to journal › Article
- 2002
-
Mark
Inhibitory effect on arterial injury-induced neointimal formation by adoptive B-cell transfer in Rag-1 knockout mice.
(
- Contribution to journal › Article